Biomedical Engineering Reference
In-Depth Information
118. Croop JM. 1993. P-Glycoprotein structure and evolutionary homologies. Cytotechnology
12:1-32.
119. Michaelis S, Berkower C. 1995. Sequence comparison of yeast ATP-binding cassette
proteins. Cold Spring Harbor Symp Quant Biol 60:291-307.
120. Riordan JR, Ling V. 1979. Purification of P-glycoprotein from plasma membrane vesicles
of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem
254:12701-12705.
121. Lum BL, Gosland MP, Kaubisch S, Sikic BI. 1993. Molecular targets in oncology: im-
plications of the multidrug resistance gene. Pharmacotherapy 13:88-109.
122. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaffeler E, Eichel-
baum M, Brinkmann U, Roots I. 2001. Frequency of single-nucleotide polymorphisms in
the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther
69:169-174.
123. Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS, Lee CG. 2002. Distinct
haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter
gene locus in three ethnic Asian populations. Pharmacogenetics 12:437-450.
124. Verstuyft C, Schwab M, Schaffeler E, Kerb R, Brinkmann U, Jaillon P, Funck-Brentano
C, Becquemont L. 2003. Digoxin pharmacokinetics and MDR1 genetic polymorphisms.
Eur J Clin Pharmacol 58:809-812.
125. Johne A, Kopke K, Gerloff T, Mai I, Rietbrock S, Meisel C, Hoffmeyer S, Kerb R,
Fromm MF, Brinkmann U, et al. 2002. Modulation of steady-state kinetics of digoxin by
haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther 72:584-594.
126. Gerloff T, Schaefer M, Johne A, Oselin K, Meisel C, Cascorbi I, Roots I. 2002. MDR1
genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy
white males. Br J Clin Pharmacol 54:610-616.
127. Chowbay B, Li H, David M, Cheung YB, Lee EJ. 2005. Meta-analysis of the influence of
MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.
Br J Clin Pharmacol 60:159-171.
128. Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ,
Shin SG. 2004. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Clin Pharmacol Ther 76:418-427.
129. Min DI, Ellingrod VL. 2002. C3435T mutation in exon 26 of the human MDR1 gene and
cyclosporine pharmacokinetics in healthy subjects. Ther Drug Monit 24:400-404.
130. Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, Freund D, Schakel
U, Ehninger G, Schaich M. 2002. MDR1 gene polymorphisms affect therapy outcome in
acute myeloid leukemia patients. Cancer Res 62:4955-4962.
131. Kim DW, Kim M, Lee SK, Kang R, Lee SY. 2006. Lack of association between
C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy.
Seizure 15:344-347.
132. Albermann N, Schmitz-Winnenthal FH, Z'Graggen K, Volk C, Hoffmann MM, Haefeli
WE, Weiss J. 2005. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1,
MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and
their relationship with the expression in intestine and liver. Biochem Pharmacol 70:949-
958.
133. Jorajuria S, Dereuddre-Bosquet N, Becher F, Martin S, Porcheray F, Garrigues A,
Mabondzo A, Benech H, Grassi J, Orlowski S, Dormont D, Clayette P. 2004. ATP binding
Search WWH ::
Custom Search